Wróć

Wybierz swój region

Corporate

Europa:

Flaga Albania Albania Flaga Bośnia i Hercegowina Bośnia i Hercegowina Flaga Bułgaria Bułgaria Flaga Chorwacja Chorwacja Flaga Cypr Cypr Flaga Czarnogóra Czarnogóra Flaga Czechy Czechy Flaga Dania Dania Flaga Estonia Estonia Flaga Hiszpania Hiszpania Flaga Kosowo Kosowo Flaga Litwa Litwa Flaga Łotwa Łotwa Flaga Luksemburg Luksemburg Flaga Macedonia Macedonia Flaga Niemcy Niemcy Flaga Polska Polska Flaga Portugalia Portugalia Flaga Rumunia Rumunia Flaga Serbia Serbia Flaga Słowacja Słowacja Flaga Słowenia Słowenia Flaga Szwajcaria Szwajcaria Flaga Szwecja Szwecja Flaga Turcja Turcja Flaga Węgry Węgry Flaga Wielka Brytania Wielka Brytania Flaga Włochy Włochy

Azja:

Flaga UAE UAE Flaga Hong Kong Hong Kong Flaga Kuwejt Kuwejt Flaga Liban Liban

Afryka:

Flaga RPA RPA

Umów konsultację o krwi pępowinowej

Umawiam

Skontaktuj się z nami już dziś!

Chcesz dowiedzieć się więcej o naszych usługach? Uzupełnij poniższy formularz, a my skontaktujemy się z Tobą jak najszybciej, aby udzielić Ci wszelkich potrzebnych informacji oraz odpowiedzieć na Twoje pytania.

    Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych Sp. z o.o. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

    Zestawienie leczonych pacjentów

    Terapie
    komórkami macierzystymi

    Terapie komórkami macierzystymi

    Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).

    Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.

    Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.

    Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.

    Data aktualizacji: 06.2026

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
    Lp. Źródło Typ źródła Wskazanie Obszar medycyny Rok podania Terapia Kraj Wiek odbiorcy
    3401 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2021 Experimental Therapy Poland 23
    3402 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2021 Experimental Therapy Poland 22
    3403 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2021 Experimental Therapy Poland 3
    3404 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2021 Experimental Therapy Poland 5
    3405 Cord Tissue Allogeneic – Related Cerebral Palsy Neurology 2021 Experimental Therapy Poland 8
    3406 Cord Tissue Allogeneic – Related Cerebral Palsy Neurology 2021 Experimental Therapy Romania 11
    3407 Cord Tissue Allogeneic – Unrelated Cerebral Palsy; Developmental Delay Neurology 2021 Experimental Therapy Poland 12
    3408 Cord Tissue Allogeneic – Unrelated Cerebral Palsy; Devic Syndrome Neurology 2021 Experimental Therapy Poland 32
    3409 Cord Tissue Allogeneic – Unrelated Chronic Graft Versus Host Disease Hematology 2021 Experimental Therapy Poland 2
    3410 Cord Tissue Allogeneic – Unrelated Condition After Cerebral Infarction Neurology 2021 Experimental Therapy Poland 42
    3411 Cord Tissue Allogeneic – Unrelated Condition After Knee Injury Orthopedy 2021 Experimental Therapy Poland 54
    3412 Cord Tissue Allogeneic – Unrelated Condition After Knee Injury Orthopedy 2021 Experimental Therapy Poland 40
    3413 Cord Tissue Allogeneic – Unrelated Coxarthrosis Orthopedy 2021 Experimental Therapy Poland 69
    3414 Cord Tissue Allogeneic – Unrelated Coxarthrosis Orthopedy 2021 Experimental Therapy Poland 55
    3415 Cord Tissue Allogeneic – Unrelated Coxarthrosis Orthopedy 2021 Experimental Therapy Poland 50
    3416 Cord Tissue Allogeneic – Unrelated Degenerative Disease Of The Spine Orthopedy 2021 Experimental Therapy Poland 51
    3417 Cord Tissue Allogeneic – Unrelated Degenerative Disease Of The Spine Orthopedy 2021 Experimental Therapy Poland 56
    3418 Cord Tissue Allogeneic – Unrelated Delayed Psychomotor Development Neurology 2021 Experimental Therapy Poland 6
    3419 Cord Tissue Allogeneic – Unrelated Duchenne Muscular Dystrophy (Dmd) Neurology 2021 Experimental Therapy Poland 27
    3420 Cord Tissue Allogeneic – Related Duchenne Muscular Dystrophy (Dmd) Hematology 2021 Experimental Therapy Turkey 25
    3421 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2021 Experimental Therapy Poland 35
    3422 Cord Tissue Allogeneic – Unrelated Encephalopathy; Global Developmental Delay Neurology 2021 Experimental Therapy Poland 2
    3423 Cord Tissue Allogeneic – Unrelated Encephalopathy; Global Developmental Delay Neurology 2021 Experimental Therapy Poland 6
    3424 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3425 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3426 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3427 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Experimental Therapy Poland 0
    3428 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Experimental Therapy Poland 21
    3429 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3430 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3431 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3432 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3433 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3434 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Experimental Therapy Poland 0
    3435 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3436 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3437 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3438 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3439 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3440 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3441 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Experimental Therapy Poland 0
    3442 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Experimental Therapy Poland 0
    3443 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Experimental Therapy Poland 0
    3444 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2021 Experimental Therapy Poland 0
    3445 Cord Tissue Allogeneic – Unrelated Epilepsy Neurology 2021 Experimental Therapy Poland 6
    3446 Cord Tissue Allogeneic – Unrelated Epilepsy Neurology 2021 Experimental Therapy Poland 9
    3447 Cord Tissue Allogeneic – Unrelated Epilepsy Neurology 2021 Experimental Therapy Poland 9
    3448 Cord Tissue Allogeneic – Unrelated Epilepsy Neurology 2021 Experimental Therapy Poland 2
    3449 Cord Tissue Allogeneic – Unrelated Epilepsy Neurology 2021 Experimental Therapy Poland 5
    3450 Cord Tissue Allogeneic – Unrelated Epileptic Encephalopathy; Global Developmental Delay Neurology 2021 Experimental Therapy Poland 2
    3451 Cord Tissue Allogeneic – Unrelated Global Developmental Delay Neurology 2021 Experimental Therapy Poland 5
    3452 Cord Tissue Allogeneic – Related Global Developmental Delay Neurology 2021 Experimental Therapy Poland 2
    3453 Cord Tissue Allogeneic – Unrelated Global Developmental Delay; Encephalopathy Neurology 2021 Experimental Therapy Poland 2
    3454 Cord Tissue Allogeneic – Unrelated Global Developmental Delay; Encephalopathy Neurology 2021 Experimental Therapy Poland 7
    3455 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 59
    3456 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 48
    3457 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 53
    3458 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 40
    3459 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 62
    3460 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 63
    3461 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 72
    3462 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 58
    3463 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 46
    3464 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 50
    3465 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 51
    3466 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 52
    3467 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2021 Experimental Therapy Poland 4
    3468 Cord Tissue Allogeneic – Unrelated Hemiparesis Neurology 2021 Experimental Therapy Poland 37
    3469 Cord Tissue Allogeneic – Unrelated Hypoxia-Ischemic Encephalopathy (Hie) Neurology 2021 Experimental Therapy Poland 30
    3470 Cord Tissue Allogeneic – Unrelated Hypoxia-Ischemic Encephalopathy (Hie) Neurology 2021 Experimental Therapy Poland 7
    3471 Cord Tissue Allogeneic – Unrelated Internal Damage To The Knee Joint Orthopedy 2021 Experimental Therapy Poland 44
    3472 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 5
    3473 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 10
    3474 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 5
    3475 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 4
    3476 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 2
    3477 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 9
    3478 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 4
    3479 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 5
    3480 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 5
    3481 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2021 Experimental Therapy Poland 1
    3482 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2021 Experimental Therapy Poland 1
    3483 Cord Tissue Allogeneic – Unrelated Myotonic Dystrophy Neurology 2021 Experimental Therapy Poland 50
    3484 Cord Tissue Allogeneic – Unrelated Nervous System Degeneration Neurology 2021 Experimental Therapy Poland 56
    3485 Cord Tissue Allogeneic – Unrelated Non-Hodkin Lymphoma; Chronic Graft Versus Host Disease Hematology 2021 Experimental Therapy Poland 14
    3486 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2021 Experimental Therapy Poland 13
    3487 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2021 Experimental Therapy Poland 26
    3488 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2021 Experimental Therapy Poland 45
    3489 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2021 Experimental Therapy Poland 27
    3490 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2021 Experimental Therapy Poland 22
    3491 Cord Tissue Allogeneic – Unrelated Osteoarthritis Orthopedy 2021 Experimental Therapy Poland 57
    3492 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2021 Experimental Therapy Poland 29
    3493 Cord Tissue Allogeneic – Unrelated Soft Tissue Diseases Orthopedy 2021 Experimental Therapy Poland 68
    3494 Cord Tissue Allogeneic – Unrelated Soft Tissue Diseases Orthopedy 2021 Experimental Therapy Poland 52
    3495 Cord Tissue Allogeneic – Unrelated Soft Tissue Diseases Related To Use, Overload And Pressure Orthopedy 2021 Experimental Therapy Poland 24
    3496 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Neurology 2021 Experimental Therapy Poland 24
    3497 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Neurology 2021 Experimental Therapy Poland 4
    3498 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Neurology 2021 Experimental Therapy Poland 30
    3499 Cord Tissue Allogeneic – Unrelated Thermal Injury Dermatology 2021 Clinical Trial BIOOPA Poland 0
    3500 Cord Tissue Allogeneic – Unrelated Venous Leg Ulcer Dermatology 2021 Clinical Trial BIOOPA Poland 0